The Yale Botulinum Program provides diagnostic and therapeutic treatment of patients with hyperactive neurological disorders such as Cervical Dystonia, Hemifacial Spasm, Blepharospasm, Limb Dystonia , and Spasticity. We also treat other conditions such as chronic migraine and severe axillary hyperhidrosis. We will evaluate and design a treatment plan for these patients and work with referring physicians to assist in their care. We use onabotulinumtoxinA (BOTOX), abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin) and rimabotulinumtoxinB (Myobloc), and we welcome new patients. We also conduct clinical trials to evaluate new treatments as they become available. Electromyographic guidance is available in selected patients.
Postal inquiries can be sent to: